Belhage B, Hansen G H, Meier E, Schousboe A
PharmaBiotec Research Center, Department of Biochemistry A, Panum Institute, University of Copenhagen, Denmark.
J Neurochem. 1990 Oct;55(4):1107-13. doi: 10.1111/j.1471-4159.1990.tb03112.x.
The effect of inhibitors of protein synthesis (actinomycin D, cycloheximide), proteases (leupeptin), and intracellular transport (colchicine, monensin) on the gamma-aminobutyric acid (GABA) agonist [4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP)]-induced changes in morphological differentiation and GABA receptor expression was investigated in cultured cerebellar granule cells. After 4 days in culture the neurons were exposed to the inhibitors for 6 h in the simultaneous presence of THIP. Subsequently, cultures were either fixed for electron microscopic examination or used for preparation of membranes for [3H]GABA binding assays. In some experiments the functional activity of the newly induced low-affinity GABA receptors was assessed by investigation of the ability of GABA to inhibit neurotransmitter release from the neurons. These experiments were performed to differentiate between an intracellular and a plasma membrane localization of the receptors. In all experiments cultures treated with THIP alone served as controls. The inhibitors of protein synthesis totally abolished the ability of THIP to induce low-affinity GABA receptors. In contrast, the inhibitors of intracellular transport as well as the protease inhibitor did not affect this parameter. However, studies of effects of GABA on transmitter release from monensin-treated cultures showed that transmitter release could not be inhibited by GABA in these cells in spite of the presence of low-affinity GABA receptors in the membrane preparations. This indicates that the low-affinity receptors were not located in the plasma membrane. This is in good agreement with the corresponding morphological findings, that monensin treatment led to an intense vacuolization of the Golgi apparatus, thereby preventing intracellular transport of the newly synthesized GABA receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
在培养的小脑颗粒细胞中,研究了蛋白质合成抑制剂(放线菌素D、环己酰亚胺)、蛋白酶抑制剂(亮抑酶肽)和细胞内运输抑制剂(秋水仙碱、莫能菌素)对γ-氨基丁酸(GABA)激动剂[4,5,6,7-四氢异恶唑并[5,4-c]吡啶-3-醇(THIP)]诱导的形态分化和GABA受体表达变化的影响。培养4天后,神经元在THIP存在的情况下同时暴露于抑制剂6小时。随后,将培养物固定用于电子显微镜检查,或用于制备用于[3H]GABA结合测定的膜。在一些实验中,通过研究GABA抑制神经元神经递质释放的能力来评估新诱导的低亲和力GABA受体的功能活性。进行这些实验是为了区分受体在细胞内和质膜的定位。在所有实验中,仅用THIP处理的培养物作为对照。蛋白质合成抑制剂完全消除了THIP诱导低亲和力GABA受体的能力。相反,细胞内运输抑制剂和蛋白酶抑制剂均不影响该参数。然而,对GABA对莫能菌素处理的培养物中递质释放影响的研究表明,尽管膜制剂中存在低亲和力GABA受体,但这些细胞中的递质释放不能被GABA抑制。这表明低亲和力受体不在质膜中。这与相应的形态学发现非常一致,即莫能菌素处理导致高尔基体强烈空泡化,从而阻止了新合成的GABA受体的细胞内运输。(摘要截断于250字)